Atlanta Consulting Group Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Atlanta Consulting Group Advisors's LLY Position: Q2 2026 in Review
Atlanta Consulting Group Advisors increased its Eli Lilly (LLY) stake by 53% in Q2 2026, buying an estimated $390K and bringing the position to 1,103 shares worth $1.32M. The position accounts for 0.21% of the portfolio, ranked #68.
Atlanta Consulting Group Advisors first reported a position in LLY in Q1 2024 and has held it in 10 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Atlanta Consulting Group Advisors held 1,103 shares of Eli Lilly worth $1.32M as of Q2 2026.
- Atlanta Consulting Group Advisors bought 382 Eli Lilly shares in Q2 2026, an estimated $390K.
- Eli Lilly made up 0.21% of Atlanta Consulting Group Advisors's portfolio in Q2 2026, its #68 holding.
- Atlanta Consulting Group Advisors first reported a position in Eli Lilly in Q1 2024 and has held it in 10 quarters since.
- 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Atlanta Consulting Group Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.